Heron Therapeutics, Inc. (HRTX)
0.361
-0.02
(-4.12%)
USD |
NASDAQ |
Oct 16, 16:00
0.3684
+0.01
(+2.05%)
After-Hours: 20:00
Heron Therapeutics Net Income (TTM) : -34.05M for June 30, 2026
Net Income (TTM) Chart
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | -34.05M |
| March 31, 2026 | -30.94M |
| December 31, 2025 | -20.20M |
| September 30, 2025 | -13.58M |
| June 30, 2025 | -0.931M |
| March 31, 2025 | -7.785M |
| December 31, 2024 | -13.58M |
| September 30, 2024 | -27.97M |
| June 30, 2024 | -48.13M |
| March 31, 2024 | -80.95M |
| December 31, 2023 | -110.56M |
| September 30, 2023 | -119.70M |
| June 30, 2023 | -136.60M |
| March 31, 2023 | -150.90M |
| December 31, 2022 | -182.02M |
| September 30, 2022 | -216.80M |
| June 30, 2022 | -227.30M |
| March 31, 2022 | -231.96M |
| December 31, 2021 | -220.68M |
| September 30, 2021 | -228.32M |
| June 30, 2021 | -234.14M |
| March 31, 2021 | -228.31M |
| December 31, 2020 | -227.28M |
| September 30, 2020 | -222.92M |
| June 30, 2020 | -198.28M |
| Date | Value |
|---|---|
| March 31, 2020 | -193.32M |
| December 31, 2019 | -204.75M |
| September 30, 2019 | -196.39M |
| June 30, 2019 | -201.14M |
| March 31, 2019 | -189.59M |
| December 31, 2018 | -178.84M |
| September 30, 2018 | -191.77M |
| June 30, 2018 | -195.29M |
| March 31, 2018 | -199.42M |
| December 31, 2017 | -197.48M |
| September 30, 2017 | -182.96M |
| June 30, 2017 | -189.60M |
| March 31, 2017 | -190.03M |
| December 31, 2016 | -173.14M |
| September 30, 2016 | -156.42M |
| June 30, 2016 | -130.58M |
| March 31, 2016 | -110.47M |
| December 31, 2015 | -97.59M |
| September 30, 2015 | -86.97M |
| June 30, 2015 | -83.50M |
| March 31, 2015 | -79.40M |
| December 31, 2014 | -76.37M |
| September 30, 2014 | -69.79M |
| June 30, 2014 | -63.46M |
| March 31, 2014 | -59.87M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Tonix Pharmaceuticals Holding Corp. | -159.67M |
| ACADIA Pharmaceuticals, Inc. | 380.48M |
| Alnylam Pharmaceuticals, Inc. | 807.99M |
| Anika Therapeutics, Inc. | -3.121M |
| Savara, Inc. | -139.31M |